We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effect of tecastemizole on pulmonary and cutaneous allergic inflammatory responses.
- Authors
Lever, R.; Hefni, A.; Moffatt, J. D.; Paul, W.; Page, C. P.
- Abstract
Background Tecastemizole, a major metabolite of astemizole, is a potent and selective H1 receptor antagonist. Evidence suggests that this and certain other H1 receptor antagonists may possess anti-inflammatory effects that are, in some cases, independent of H1 receptor antagonism. Objective The aim of this study was to investigate the anti-inflammatory effects of tectastemizole in models of allergic inflammation. Methods Effects of tecastemizole were assessed in a murine model of allergic lung inflammation, in passive cutaneous anaphylaxis (PCA) responses in guinea-pig skin and in in vitro assays measuring endothelial adhesion molecule expression and leucocyte–endothelial adhesion. Results Tecastemizole inhibited antigen-induced eosinophil recruitment to the lungs of allergic mice in a dose-dependent manner. Furthermore, combination of a sub-effective dose of tecastemizole, combined with a sub-effective dose of dexamethasone inhibited eosinophil accumulation in this model. Plasma extravasation in PCA reactions was inhibited by tecastemizole, although by a mechanism that would appear to be H1 receptor-dependent. Cytokine-induced endothelial intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression, as well as mononuclear cell adhesion to human umbilical vein endothelial cells was inhibited by tecastemazole in a manner independent of H1 receptor antagonism. Conclusion These data suggest that tecastemizole may have H1 receptor-independent effects in inhibiting late-phase inflammatory responses, while acute responses appear to be inhibited in a H1 receptor-dependent manner. Furthermore, our data suggest an important potential steroid-sparing role for such drugs in the treatment of allergic inflammatory conditions.
- Subjects
ASTEMIZOLE; ALLERGIES; INFLAMMATION; MEDICINE; CARDIOPULMONARY system
- Publication
Clinical & Experimental Allergy, 2007, Vol 37, Issue 6, p909
- ISSN
0954-7894
- Publication type
Article
- DOI
10.1111/j.1365-2222.2007.02730.x